SEC Form 4 · accession 0001493152-15-000447
CardioGenics Holdings Inc. · CGNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Essex
Officer — CHIEF FINANCIAL OFFICER · Director
Period of report
Feb 5, 2015
Accepted (ET)
Feb 11, 2015 · 10:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001089029
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2015 | P | 234,302 | $0.11 | A | 759,985 | D | |
| Common Stock | Feb 5, 2015 | P | 227,273 | $0.11 | A | 987,258 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Debenture Series B | $0.11 | Feb 5, 2015 | C | 1 | D | Jun 3, 2013 | Jun 3, 2016 | Common Stock | 234,302 | 0 | D |